HIGH-DOSE THERAPY AND AUTOLOGOUS BONE-MARROW STEM-CELL TRANSPLANTATION (ABMT) AS CONSOLIDATION THERAPY DURING FIRST CR PR IN PATIENTS WITH POOR-RISK INTERMEDIATE-AND HIGH-GRADE LYMPHOMA/

Citation
A. Nademanee et al., HIGH-DOSE THERAPY AND AUTOLOGOUS BONE-MARROW STEM-CELL TRANSPLANTATION (ABMT) AS CONSOLIDATION THERAPY DURING FIRST CR PR IN PATIENTS WITH POOR-RISK INTERMEDIATE-AND HIGH-GRADE LYMPHOMA/, Blood, 88(10), 1996, pp. 2725-2725
Citations number
NO
Categorie Soggetti
Hematology
Journal title
BloodACNP
ISSN journal
00064971
Volume
88
Issue
10
Year of publication
1996
Part
1
Supplement
1
Pages
2725 - 2725
Database
ISI
SICI code
0006-4971(1996)88:10<2725:HTAABS>2.0.ZU;2-L